EcoDrugPlus

Histone Deacetylase 11

Ensembl ID : ENSCLAG00000009712
Gene Symbol: HDAC11
3 Cross references
198 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSCLAG00000000749
Gene Symbol: HDAC2
2 Cross references
201 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSCLAG00000014357
Gene Symbol: HDAC3
3 Cross references
156 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSCLAG00000003187
Gene Symbol: HDAC4
3 Cross references
263 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSCLAG00000015499
Gene Symbol: HDAC5
2 Cross references
194 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSCLAG00000002563
Gene Symbol: HDAC6
3 Cross references
183 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSCLAG00000003217
Gene Symbol: HDAC7
2 Cross references
263 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSCLAG00000015755
Gene Symbol: HDAC8
2 Cross references
204 Possible Orthologues:

Histone Deacetylase 9

Ensembl ID : ENSCLAG00000007911
Gene Symbol: HDAC9
3 Cross references
233 Possible Orthologues:

Hydroxycarboxylic Acid Receptor 2

Ensembl ID : ENSCLAG00000017988
Gene Symbol: HCAR2
1 Cross references
164 Possible Orthologues:

Hydroxysteroid 11-Beta Dehydrogenase 1

Ensembl ID : ENSCLAG00000001865
Gene Symbol: HSD11B1
2 Cross references
267 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSCLAG00000007756
Gene Symbol: HCN4
3 Cross references
288 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).